BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 34340212)

  • 1. Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
    Shah MH; Goldner WS; Benson AB; Bergsland E; Blaszkowsky LS; Brock P; Chan J; Das S; Dickson PV; Fanta P; Giordano T; Halfdanarson TR; Halperin D; He J; Heaney A; Heslin MJ; Kandeel F; Kardan A; Khan SA; Kuvshinoff BW; Lieu C; Miller K; Pillarisetty VG; Reidy D; Salgado SA; Shaheen S; Soares HP; Soulen MC; Strosberg JR; Sussman CR; Trikalinos NA; Uboha NA; Vijayvergia N; Wong T; Lynn B; Hochstetler C
    J Natl Compr Canc Netw; 2021 Jul; 19(7):839-868. PubMed ID: 34340212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018.
    Shah MH; Goldner WS; Halfdanarson TR; Bergsland E; Berlin JD; Halperin D; Chan J; Kulke MH; Benson AB; Blaszkowsky LS; Eads J; Engstrom PF; Fanta P; Giordano T; He J; Heslin MJ; Kalemkerian GP; Kandeel F; Khan SA; Kidwai WZ; Kunz PL; Kuvshinoff BW; Lieu C; Pillarisetty VG; Saltz L; Sosa JA; Strosberg JR; Sussman CA; Trikalinos NA; Uboha NA; Whisenant J; Wong T; Yao JC; Burns JL; Ogba N; Zuccarino-Catania G
    J Natl Compr Canc Netw; 2018 Jun; 16(6):693-702. PubMed ID: 29891520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary Neuroendocrine Tumors: Providing Comprehensive Care for Individuals Who Have a Germline Pathogenic Variant Associated With Paragangliomas and Pheochromocytomas.
    Mahon SM
    Clin J Oncol Nurs; 2021 Apr; 25(2):137-141. PubMed ID: 33739340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma.
    Fishbein L; Del Rivero J; Else T; Howe JR; Asa SL; Cohen DL; Dahia PLM; Fraker DL; Goodman KA; Hope TA; Kunz PL; Perez K; Perrier ND; Pryma DA; Ryder M; Sasson AR; Soulen MC; Jimenez C
    Pancreas; 2021 Apr; 50(4):469-493. PubMed ID: 33939658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of tumors of the adrenal medulla.
    Ilias I; Pacak K
    Horm Metab Res; 2005 Dec; 37(12):717-21. PubMed ID: 16372223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine tumors, version 1.2015.
    Kulke MH; Shah MH; Benson AB; Bergsland E; Berlin JD; Blaszkowsky LS; Emerson L; Engstrom PF; Fanta P; Giordano T; Goldner WS; Halfdanarson TR; Heslin MJ; Kandeel F; Kunz PL; Kuvshinoff BW; Lieu C; Moley JF; Munene G; Pillarisetty VG; Saltz L; Sosa JA; Strosberg JR; Vauthey JN; Wolfgang C; Yao JC; Burns J; Freedman-Cass D;
    J Natl Compr Canc Netw; 2015 Jan; 13(1):78-108. PubMed ID: 25583772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine tumors.
    Kulke MH; Benson AB; Bergsland E; Berlin JD; Blaszkowsky LS; Choti MA; Clark OH; Doherty GM; Eason J; Emerson L; Engstrom PF; Goldner WS; Heslin MJ; Kandeel F; Kunz PL; Kuvshinoff BW; Moley JF; Pillarisetty VG; Saltz L; Schteingart DE; Shah MH; Shibata S; Strosberg JR; Vauthey JN; White R; Yao JC; Freedman-Cass DA; Dwyer MA;
    J Natl Compr Canc Netw; 2012 Jun; 10(6):724-64. PubMed ID: 22679117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCSK2 expression in neuroendocrine tumors points to a midgut, pulmonary, or pheochromocytoma-paraganglioma origin.
    Remes SM; Leijon H; Vesterinen T; Louhimo J; Pulkkinen V; Ezer S; Kere J; Haglund C; Arola J
    APMIS; 2020 Nov; 128(11):563-572. PubMed ID: 32794589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pheochromocytomas and Paragangliomas.
    Tevosian SG; Ghayee HK
    Endocrinol Metab Clin North Am; 2019 Dec; 48(4):727-750. PubMed ID: 31655773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine manifestations of von Hippel-Lindau disease.
    Cassol C; Mete O
    Arch Pathol Lab Med; 2015 Feb; 139(2):263-8. PubMed ID: 25611110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.
    Garcia-Carbonero R; Matute Teresa F; Mercader-Cidoncha E; Mitjavila-Casanovas M; Robledo M; Tena I; Alvarez-Escola C; Arístegui M; Bella-Cueto MR; Ferrer-Albiach C; Hanzu FA
    Clin Transl Oncol; 2021 Oct; 23(10):1995-2019. PubMed ID: 33959901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical aspects, diagnostic challenges and management of patients with neuroendocrine tumors (NETs).
    Spizzo G; Bernardini K; Pieramico O; Buratti T; Platzgummer S; Farsad M; Schmitt AM; Perren A; Vogelsang H; Promegger R; Bale R; Gabriel M; Nevinny M; Gastl G; Mitterer M
    Onkologie; 2011; 34(3):139-46. PubMed ID: 21358221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of gastric and duodenal neuroendocrine tumors.
    Sato Y; Hashimoto S; Mizuno K; Takeuchi M; Terai S
    World J Gastroenterol; 2016 Aug; 22(30):6817-28. PubMed ID: 27570419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Various neuroendocrine tumors in a family with multiple endocrine neoplasia type 1].
    Sepp K; Valkusz Z
    Orv Hetil; 2013 Dec; 154(51):2037-42. PubMed ID: 24334135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential diagnostic value of the expression of the transcription factor PDX-1 in neuroendocrine and non-neuroendocrine tumors of the pancreas and other organs].
    Gurevich LE; Proshchina AE; Voronkova IA; Ashevskaya VE; Korosteleva PA; Dolzhansky OV
    Arkh Patol; 2019; 81(5):11-21. PubMed ID: 31626200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors.
    Strosberg JR; Halfdanarson TR; Bellizzi AM; Chan JA; Dillon JS; Heaney AP; Kunz PL; O'Dorisio TM; Salem R; Segelov E; Howe JR; Pommier RF; Brendtro K; Bashir MA; Singh S; Soulen MC; Tang L; Zacks JS; Yao JC; Bergsland EK
    Pancreas; 2017 Jul; 46(6):707-714. PubMed ID: 28609356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus).
    Phan AT; Oberg K; Choi J; Harrison LH; Hassan MM; Strosberg JR; Krenning EP; Kocha W; Woltering EA; Maples WJ;
    Pancreas; 2010 Aug; 39(6):784-98. PubMed ID: 20664476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnosis and medical management of advanced neuroendocrine tumors.
    Kaltsas GA; Besser GM; Grossman AB
    Endocr Rev; 2004 Jun; 25(3):458-511. PubMed ID: 15180952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of neuroendocrine tumors of unknown origin.
    Polish A; Vergo MT; Agulnik M
    J Natl Compr Canc Netw; 2011 Dec; 9(12):1397-402; quiz 1403. PubMed ID: 22157557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors.
    Halfdanarson TR; Strosberg JR; Tang L; Bellizzi AM; Bergsland EK; O'Dorisio TM; Halperin DM; Fishbein L; Eads J; Hope TA; Singh S; Salem R; Metz DC; Naraev BG; Reidy-Lagunes DL; Howe JR; Pommier RF; Menda Y; Chan JA
    Pancreas; 2020 Aug; 49(7):863-881. PubMed ID: 32675783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.